-
1
المؤلفون: Snježana Ramić, Frane Paić, Velda Smajlbegović, Melita Perić Balja, Lea Hiršl, Ingrid Marton, Fabijan Knežević
المصدر: Croatian Medical Journal
Volume 63
Issue 2مصطلحات موضوعية: pHER2Y1248 predicts sensitivity to trastuzumab and a better five-year DFS regardless of any other prognostic parameter. In HER2-positive BC patients. Non-phosphorylated HER2Y1248 is a strong predictor of trastuzumab resistance and a poor DFS, Trastuzumab / therapeutic use, Breast Neoplasms / drug therapy, Receptor, ErbB-2 / genetics, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Oncology, Receptor, ErbB-2, BIOMEDICINE AND HEALTHCARE. Basic Medical Sciences, Breast Neoplasms, General Medicine, Trastuzumab, Middle Aged, Receptor, ErbB-2 / metabolism, Disease-Free Survival, BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Onkologija, Humans, Female, BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572b82d9792cd15fa3372c9f0361b041
https://repository.medri.uniri.hr/islandora/object/medri:6519 -
2رسالة جامعية
المؤلفون: Hilborn, Erik
المساهمون: Linköpings universitet. Institutionen för klinisk och experimentell medicin
مصطلحات موضوعية: SNP, droplet digital PCR, HSD17B1, HSD17B2, miRNA, Breast Neoplasms -- metabolism, Chemokine CXCL10 -- metabolism, Receptors, CXCR3 -- metabolism, Antineoplastic Agents, Hormonal -- therapeutic use, Neoplasm Recurrence, Local, Estrogen Receptor alpha -- metabolism, Receptor, ErbB-2 -- metabolism, Receptors, Androgen -- metabolism, Receptors, Progesterone -- metabolism, Tamoxifen -- therapeutic use
Degree: Diss. (sammanfattning) Linköping : Linköpings universitet, 2016
-
3رسالة جامعية
المؤلفون: Xu, Li
مصطلحات موضوعية: Estrogen Receptor beta -- genetics, Estrogen Receptor beta -- metabolism, Cell Proliferation, Neoplasm Invasiveness -- genetics, Breast Neoplasms -- genetics, Breast Neoplasms -- metabolism, Receptor, erbB-2 -- metabolism, Receptor, Epidermal Growth Factor -- metabolism, Hypoxia-Inducible Factor 1, alpha Subunit -- metabolism
Degree: Diss. (sammanfattning) Stockholm : Karolinska Institutet, 2013
-
4رسالة جامعية
المؤلفون: Vu, Hong Thang
مصطلحات موضوعية: Breast Neoplasms -- ethnology, Breast Neoplasms -- mortality, Breast Neoplasms -- therapy, Tumor Markers, Biological -- analysis, Receptors, Estrogen -- analysis, Receptors, Estrogen -- metabolism, Receptors, Progesterone -- analysis, Receptors, Progesterone -- metabolism, Receptor, erbB-2 -- analysis, Receptor, erbB-2 -- metabolism, Ki-67 Antigen -- analysis, Prognosis, Developing Countries
URL الوصول: http://hdl.handle.net/10616/40909
Degree: Diss. (sammanfattning) Stockholm : Karolinska institutet, 2012
-
5
المؤلفون: Youlia Kirova, Jean-Christophe Tille, Laëtitia Furhmann, Matthieu Carton, Anne Vincent-Salomon, Anne Tardivon, Lounes Djerroudi, F Reyal, Caroline Saint-Martin, André Filipe Vieira, François-Clément Bidard
المساهمون: Hôpitaux Universitaires de Genève (HUG), Institut Curie [Paris], Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Universidade do Porto, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Fundo Regional para a Ciência e Tecnologia, FRCT, Funding AFV received support from a Mayent-Rothschild fellowship from Institut Curie, France and IPATIMUP/Fundação para a Ciência e Tecnologia, Portugal.
المصدر: Modern Pathology
Modern Pathology, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 33 (11), pp.2198-2207. ⟨10.1038/s41379-020-0561-9⟩
Modern pathology, Vol. 33, No 11 (2020) pp. 2198-2207مصطلحات موضوعية: 0301 basic medicine, Oncology, Pathology, Receptor, ErbB-2, [SDV]Life Sciences [q-bio], Estrogen receptor, ddc:616.07, Receptor, ErbB-2 / metabolism, Breast Neoplasms / metabolism, 0302 clinical medicine, Lymphocytes, Tumor-Infiltrating / immunology, Carcinoma, Lobular / metabolism, skin and connective tissue diseases, Lymph node, Breast Neoplasms / mortality, Age Factors, hemic and immune systems, Middle Aged, Prognosis, Receptors, Estrogen / metabolism, 3. Good health, Survival Rate, medicine.anatomical_structure, Receptors, Progesterone / metabolism, Receptors, Estrogen, 030220 oncology & carcinogenesis, Invasive lobular carcinoma, Breast Neoplasms / pathology, Biomarker (medicine), Nottingham Prognostic Index, Female, Receptors, Progesterone, Lymphocytes, Tumor-Infiltrating / pathology, Invasive Lobular Breast Carcinoma, medicine.medical_specialty, Carcinoma, Lobular / immunology, chemical and pharmacologic phenomena, Breast Neoplasms, Pathology and Forensic Medicine, Breast Neoplasms / immunology, Carcinoma, Lobular / mortality, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Internal medicine, medicine, Humans, Survival analysis, Retrospective Studies, Tumor-infiltrating lymphocytes, business.industry, Carcinoma, Lobular / pathology, medicine.disease, Carcinoma, Lobular, 030104 developmental biology, business
-
6
المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE)
المصدر: Clinical Chemistry
Clinical Chemistry, American Association for Clinical Chemistry, 2020, 66 (1), pp.97-104. ⟨10.1373/clinchem.2019.303586⟩مصطلحات موضوعية: 0301 basic medicine, Proto-Oncogene Proteins B-raf, Proteome, MESH: Proto-Oncogene Proteins B-raf / genetics, Receptor, ErbB-2 / genetics, Receptor, ErbB-2 / metabolism, Transcriptome, ras Proteins / genetics, Receptor, ErbB-2, Clinical Biochemistry, Programmed Cell Death 1 Receptor, MESH: Biomarkers, Tumor / genetics, Biomarkers, Tumor / metabolism, Humans, Liquid Biopsy, Neoplastic Cells, Circulating / metabolism, [SDV.CAN]Life Sciences [q-bio]/Cancer, Computational biology, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Clinical information, medicine, Biomarkers, Tumor, Functional studies, Liquid biopsy, business.industry, Biochemistry (medical), Cancer, medicine.disease, Neoplastic Cells, Circulating, 3. Good health, MESH: Neoplastic Cells, Circulating / pathology, Programmed Cell Death 1 Receptor / genetics, Programmed Cell Death 1 Receptor / metabolism, Proteome / metabolism, 030104 developmental biology, 030220 oncology & carcinogenesis, Tissue biopsies, ras Proteins, business
-
7رسالة جامعية
المؤلفون: Hallbeck, Anna-Lotta
مصطلحات موضوعية: Arthritis, rheumatoid -- metabolism, Cell differentiation -- drug effects, Interleukin 6 -- metabolism, Macrophages -- drug effects, Osteoarthritis, knee -- metabolism, Receptor erbB-2 -- metabolism, RNA, messenger -- drug effects, Receptors, interleukin-6 -- drug effects, Synovial membrane -- metabolism, Transforming growth factor alpha -- genetics, Transforming growth factor alpha -- metabolism, Up-regulation -- drug effects
Degree: Diss. (sammanfattning) Linköping : Linköpings universitet, 2007
-
8رسالة جامعية
المؤلفون: Jenndahl, Lachmi
مصطلحات موضوعية: E-erbB2, integrin alpha2beta1, integrin regulation, ILK, PKB, Rho, epithelial-mesenchymal transition (EMT), E-cadherin, Anchorage independent growth (AIG), Receptors, growth factor, Morphogenesis, Cell adhesion, Epithelial cells, Epithelial cells -- cytology, Epithelial cells -- metabolism, Epithelial cells -- drug effects, Mammary glands, animal -- cytology, Cell adhesion -- physiology, Receptor, erbB-2 -- genetics, Receptor, erbB-2 -- metabolism, Morphogenesis -- physiology, Signal transduction, Integrin alpha2beta1 -- metabolism
Degree: Diss. (sammanfattning) Göteborg : Göteborgs universitet, 2005
-
9
المؤلفون: Ban, Marija, Strikić, Ante, Petrić Miše, Branka, Vrdoljak, Eduard
المصدر: Liječnički vjesnik
Volume 141
Issue 1-2مصطلحات موضوعية: TUMORI DOJKE – farmakoterapija, metabolizam, patologija, smrtnost, HORMONSKI OVISNI TUMORI – farmakoterapija, metabolizam, patologija, smrtnost, PROTUTUMORSKI LIJEKOVI – farmakologija, neželjeni učinci, terapijska primjena, RECEPTOR ERBB-2 – metabolizam, CIKLIN OVISNA KINAZA 4 – antagonisti i inhibitori, metabolizam, CIKLIN OVISNA KINAZA 6 – antagonisti i inhibitori, metabolizam, AROMATOZNI INHIBITORI – terapijska primjena, FULVESTRANT – terapijska primjena, INHIBITORI PROTEINSKE KINAZE – neželjeni učinci, terapijska primjena, TUMORSKE METASTAZE, PREŽIVLJENJE BEZ PROGRESIJE BOLESTI, tumori dojke, hormonski ovisni tumori, protutumorski lijekovi, receptor erbb-2, ciklin ovisna kinaza 4, ciklin ovisna kinaza 6, aromatozni inhibitori, fulvestrant, inhibitori proteinske kinaze, tumorske metastaze, preživljenje bez progresije bolesti, BREAST NEOPLASMS – drug therapy, metabolism, mortality, pathology, NEOPLASMS, HORMONE-DEPENDENT – drug therapy, metabolism, mortality, pathology, ANTINEOPLASTIC AGENTS – adverse effects, pharmacology, therapeutic use, RECEPTOR, ERBB-2 – metabolism, CYCLIN-DEPENDENT KINASE 4 – antagonists and inhibitors, metabolism, CYCLIN-DEPENDENT KINASE 6 – antagonists and inhibitors, metabolism, AROMATOZNI INHIBITORI – therapeutic use, FULVESTRANT – therapeutic use, PROTEIN KINASE INHIBITORS – adverse effects, therapeutic use, NEOPLASM METASTASIS, PROGRESSION-FREE SURVIVAL
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4248c2d4b83c409d59a559a9890c027e
https://hrcak.srce.hr/218766 -
10
المؤلفون: James H. Resau, Ernst Lengyel, Katja Gauger, Beatrice S. Knudsen, Dieter Prechtel, Nadia Harbeck, Anita Welk, Kristina Lindemann, Thomas Richter, Georgia Salanti, George F. Vande Woude
المصدر: International Journal of Cancer. 113:678-682
مصطلحات موضوعية: Cancer Research, Receptors, Progesterone/metabolism, Receptor, ErbB-2, Estrogen receptor, Pilot Projects, Ligands, HER2/neu, Receptor tyrosine kinase, Metastasis, chemistry.chemical_compound, Risk Factors, Fibrocystic Breast Disease, Aged, 80 and over, Hepatocyte Growth Factor, Proto-Oncogene Proteins c-met/*metabolism, Middle Aged, Proto-Oncogene Proteins c-met, Survival Rate, Treatment Outcome, Receptors, Estrogen, Oncology, Receptor, erbB-2/*metabolism, Lymphatic Metastasis, Disease Progression, Breast Neoplasms/drug therapy/*metabolism/*pathology, Immunohistochemistry, Female, Hepatocyte growth factor, Receptors, Estrogen/metabolism, Receptors, Progesterone, Fibrocystic Breast Disease/drug therapy/metabolism/pathology, medicine.drug, Adult, C-Met, Hepatocyte Growth Factor/metabolism, Breast Neoplasms, Biology, Disease-Free Survival, Lymphatic Metastasis/*pathology, Progesterone receptor, medicine, Humans, Aged, Neoplasm Staging, Hyperplasia, medicine.disease, chemistry, Hyperplasia/drug therapy/metabolism/pathology, Lymph Nodes/pathology, Cancer research, biology.protein, Lymph Nodes